In vitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddI

This publication has 21 references indexed in Scilit:

• Quiescent T Lymphocytes as an Inducible Virus Reservoir in HIV-1 Infection
  Science, 2006
• Human Immunodeficiency Virus Type 1 (HIV-l) Viremia Changes and Development of Drug-Related Mutations in Patients with Symptomatic HIV-l Infection Receiving Alternating or Simultaneous Zidovudine and Didanosine Therapy
  The Journal of Infectious Diseases, 1995
• In vitroanti-HIV and Cytotoxicological Evaluation of the Triple Combination: AZT and ddC with HIV Proteinase Inhibitor Saquinavir (Ro 31-8959)
  Antiviral Chemistry and Chemotherapy, 1994
• AC₂Symmetry-Based HIV Protease Inhibitor, A77003, Irreversibly Inhibits Infectivity of HIV-1In Vitro
  AIDS Research and Human Retroviruses, 1994
• Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
  Journal of Clinical Investigation, 1993
• In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine
  Antimicrobial Agents and Chemotherapy, 1993
• In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations
  Antimicrobial Agents and Chemotherapy, 1992
• COMBO: A New Approach to the Analysis of Drug Combinations in Vitro^a
  Annals of the New York Academy of Sciences, 1990
• Design, Activity, and 2.8 Å Crystal Structure of a C ₂ Symmetric Inhibitor Complexed to HIV-1 Protease
  Science, 1990
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987